Authors: Shechter, Y Goldwaser, I Lavon, I Gershonov, E Mester, B Mironchik, M Patt, LP Fridkin, M

Citation: Y. Shechter et al., A new approach for prolonging the half-life of peptides, proteins and low-molecular-weight drugs in vivo, DRUG FUTURE, 26(7), 2001, pp. 669-676

Authors: Lavon, I Goldberg, I Amit, S Landsman, L Jung, S Tsuberi, BZ Barshack, I Kopolovic, J Galun, E Bujard, H Ben-Neriah, Y

Citation: I. Lavon et al., High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-kappa B activation, NAT MED, 6(5), 2000, pp. 573-577

Authors: Yaron, A Hatzubai, A Davis, M Lavon, I Amit, S Manning, AM Andersen, JS Mann, M Mercurio, F Ben-Neriah, Y

Citation: A. Yaron et al., Identification of the receptor component of the I kappa B alpha-ubiquitin ligase, NATURE, 396(6711), 1998, pp. 590-594